17 June 2024
: Case report 
Genome Sequencing Analysis of a Rare Case of Blood Infection Caused by Flavonifractor plautii
Challenging differential diagnosis, Management of emergency care, Patient complains / malpractice, Unexpected drug reaction, Rare disease, Clinical situation which can not be reproduced for ethical reasons
Xingying Chen1ABCD, Wei Bi1ABCDE, Xinyi Ruan2AB, Limin Jin1ABEFG, Nenghua Zhang1ABCDEFG*DOI: 10.12659/AJCR.943920
Am J Case Rep 2024; 25:e943920
Table 1. Drug sensitivity test results of Flavonifractor plautii.
| Substance | MIC (μg/L) | Breakpoint range in μg/L (CLSI) |
|---|---|---|
| Penicillin | 0.50 | S(0.5–2) |
| Ampicillin | 0.50 | S(0.5–2) |
| Piperacillin tazobactam | 2/4 | S(16/4–128/4) |
| Cefatriaxone | 0.50–1.00 | S(16–64) |
| Imipenem | 0.12 | S(4–16) |
| Meropenem | <0.01 | S(4–16) |
| Tetracycline | 32.00 | R (4–16) |
| Ciprofloxacin | >32.00 | R(2–8) |
| Levofloxacin | 8.00 | R(2–8) |
| Clindamycin | 0.25 | S(2–8) |
| Chloramphenicol | 2.00 | S(8–32) |
| Metronidazole | <0.01 | S(8–32) |
| * CLSI breakpoints for gram-positive anaerobes are utilized; # CLSI non-species-related breakpoints are utilized. CLSI is the abbreviation of Clinical and Laboratory Standards Institute. | ||